CDH1 and nonpapillary renal cell carcinoma: Concurrent with these phenotypic changes are an assortment of molecular changes, including loss of epithelial markers such as E-cadherin, a common occurrence in clinical ccRCC specimens31, 36, and gain of mesenchymal markers such as N-cadherin and alpha smooth muscle actin (α-SMA)37.